Patient Daily
  • Breakthrough
  • Community
  • People
  • Public Policy
  • Regulatory
  • Technology
  • Breakthrough
  • Community
  • People
  • Public Policy
  • Regulatory
  • Technology
  • Home
  • »
  • Stories
  • »
  • 2018
  • »
  • October
  • PRELUDE FERTILITY: Prelude Fertility and NYU Langone Health Announce Partnership Targeting Expansion of Patient Care

    Breakthrough
    Press release submission | Oct 4, 2018

    Agreement Establishes a New Stronghold in a Rapidly Expanding Fertility Market

  • SWISSLOG HEALTHCARE SOLUTIONS: Skilled Nursing Facilities Seek Solutions to Address Quality as Interest in Post-Acute Care Transitions is on the Rise

    Breakthrough
    Press release submission | Oct 4, 2018

    Long-term care facilities play a critical role in caring for the needs of a growing aging population with a lengthening lifespan.

  • MEI PHARMA INC.: MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies

    Breakthrough
    Press release submission | Oct 11, 2018

    MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced a clinical collaboration to evaluate the safety and efficacy of MEI's ME-401, an investigational PI3K delta inhibitor, in combination with BeiGene's zanubrutinib, an investigational BTK inhibitor, for the treatment of patients with B-cell malignancies.

  • THE LEUKEMIA AND LYMPHOMA SOCIETY: Receives Significant Gift to Support Promising Young Scientists

    Technology
    Press release submission | Oct 11, 2018

    The Leukemia & Lymphoma Society (LLS) continues to lead cutting-edge research to advance treatments for myeloma and lymphoma. Adding to the momentum, the organization announced a $1,175,000 commitment by the Schwartz Ward Family Foundation (SWFF) of Chicago to support two unique research initiatives including a novel therapy for a rare form of lymphoma and an innovative immunotherapy approach for multiple myeloma.

  • Genetic testing advised during adoption process

    Technology
    Karen Kidd | Oct 16, 2018

    A genetic counseling group announced earlier this week its support for genetic testing of children during the adoption process.

  • Study: Most patients don't store insulin correctly

    Breakthrough
    Marian Johns | Oct 16, 2018

    A study presented at the European Association for the Study of Diabetes found that patients are not storing their insulin at the recommended temperature ranges.

  • Study: Telemedicine closes genetic counseling gap

    Technology
    Karen Kidd | Oct 16, 2018

    Video and phone sessions can close the gap between academic-based medical settings where cancer patients are more likely to receive genetic counseling and other care settings where they may not, Penn Medicine News reported.

  • ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

    Breakthrough
    Press release submission | Oct 18, 2018

    For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack.

  • AMERICAN BRAIN TUMOR ASSOCIATION: Launches 2018 Request for Grant Applications to Continue Driving Advances in the Brain Tumor Field

    Community
    Press release submission | Oct 18, 2018

    The American Brain Tumor Association (ABTA), the nation's first nonprofit organization dedicated to brain tumor education and research, is now accepting Letters of Intent (LOI) for three research funding opportunities.

  • Think tank founder recommends standard patents over intellectual property rights to cut drug prices

    People
    Karen Kidd | Oct 23, 2018

    Reducing prescription drug prices for patients while still encouraging pharmaceutical research and development is a difficult problem to solve politically, the founder of a web-based think tank said in the wake of attack ads against candidates.

  • ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

    Breakthrough
    Press release submission | Oct 26, 2018

    New Assays empower Clinicians to more quickly make the right diagnosis at the point-of-care and prescribe the right treatment

  • ABBVIE: To Assume Full Development and Commercial Control of Cystic Fibrosis Research Program

    Technology
    Press release submission | Oct 26, 2018

    AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos (Euronext: GLPG) to discover and develop new therapies to treat cystic fibrosis (CF).



Patient Daily Newsletter
Sign-up to receive news from Patient Daily


Trending

  • SAVIDA HEALTH: Addiction Medicine Practice Opens 8th Treatment Center in Northern Shenandoah Valley

Patient Daily
  • About
  • Contact

Alerts Sign-up